|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ettinger DS: Ten years of progress in
non-small cell lung cancer. J Natl Compr Canc Netw. 10:292–295.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao F, Liu D, Guo Y, Shi B, Song Z, Tian
Y, Zhang Z and Liang C: Survival rate and prognostic factors of
surgically resected clinically synchronous multiple primary
non-small cell lung cancer and further differentiation from
intrapulmonary metastasis. J Thorac Dis. 9:990–1001. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen X, Du J, Jiang R and Li L:
MicroRNA-214 inhibits the proliferation and invasion of lung
carcinoma cells by targeting JAK1. Am J Transl Res. 10:1164–1171.
2018.PubMed/NCBI
|
|
5
|
Saumet A and Lecellier CH: microRNAs and
personalized medicine: Evaluating their potential as cancer
biomarkers. Adv Exp Med Biol. 888:5–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren P, Gong F, Zhang Y, Jiang J and Zhang
H: MicroRNA-92a promotes growth, metastasis and chemoresistance in
non-small cell lung cancer cells by targeting PTEN. Tumour Biol.
37:3215–3225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv X, Li CY, Han P and Xu XY:
MicroRNA-520a-3p inhibits cell growth and metastasis of non-small
cell lung cancer through PI3K/AKT/mTOR signaling pathway. Eur Rev
Med Pharmacol Sci. 22:2321–2327. 2018.PubMed/NCBI
|
|
10
|
Li S, Zhang J, Zhao Y, Wang F, Chen Y and
Fei X: miR-224 enhances invasion and metastasis by targeting HOXD10
in non-small cell lung cancer cells. Oncol Lett. 15:7069–7075.
2018.PubMed/NCBI
|
|
11
|
Xiong DD, Chen H, He RQ, Lan AH, Zhong JC,
Chen G, Feng ZB and Wei KL: MicroRNA-671-3p inhibits the
development of breast cancer: A study based on in vitro
experiments, in-house quantitative polymerase chain reaction and
bioinformatics analysis. Int J Oncol. 52:1801–1814. 2018.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(T)(-Delta Delta C) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang B, Li M, Ji F and Nie Y:
MicroRNA-219 exerts a tumor suppressive role in glioma via
targeting Sal-like protein 4. Exp Ther Med. 14:6213–6221.
2017.PubMed/NCBI
|
|
14
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions, : The
IASLC lung cancer staging project: Proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Onat S, Ates G, Avci A, Yildiz T, Birak A,
Akgul Ozmen C and Ulku R: The role of mediastinoscopy in the
diagnosis of non-lung cancer diseases. Ther Clin Risk Manag.
13:939–943. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu YX, Wang Y and Liu H: Overexpression of
PTEN suppresses non-small-cell lung carcinoma metastasis through
inhibition of integrin αVβ6 signaling. Am J Transl Res.
9:3304–3314. 2017.PubMed/NCBI
|
|
17
|
Wang S, Zhang B, Li C, Cui C, Yue D, Shi
B, Zhang Q, Zhang Z, Zhang X and Wang C: Prognostic value of number
of negative lymph node in patients with stage II and IIIa non-small
cell lung cancer. Oncotarget. 8:79387–79396. 2017.PubMed/NCBI
|
|
18
|
Esmatabadi MJD, Farhangi B, Montazeri M,
Monfared H, Sistani RN and Sadeghizadeh M: Up-regulation of miR-21
decreases chemotherapeutic effect of dendrosomal curcumin in breast
cancer cells. Iran J Basic Med Sci. 20:350–359. 2017.PubMed/NCBI
|
|
19
|
Du L, Chen T, Zhao K and Yang D: miR-30a
suppresses osteosarcoma proliferation and metastasis by
downregulating MEF2D expression. Onco Targets Ther. 11:2195–2202.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jeon SH, Yoo JK, Kim CM, Lim ES, Lee SJ,
Lee JM, Oh SH and Kim JK: The novel hsa-miR-12528 regulates
tumourigenesis and metastasis through hypo-phosphorylation of AKT
cascade by targeting IGF-1R in human lung cancer. Cell Death Dis.
9:4932018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu J, Pan X and Hu Z: MiR-502 mediates
esophageal cancer cell TE1 proliferation by promoting AKT
phosphorylation. Biochem Biophys Res Commun. 501:119–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu Y, Wang Z, Sun D, Zhou X, Wei X, Hou W,
Ding Y, Ma Y and Hou Y: miR-671 promotes prostate cancer cell
proliferation by targeting tumor suppressor SOX6. Eur J Pharmacol.
823:65–71. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang F, Wei K, Qin Z, Liu W, Shao C, Wang
C, Ma L, Xie M, Shu Y and Shen H: MiR-598 suppresses invasion and
migration by negative regulation of derlin-1 and
epithelial-mesenchymal transition in non-small cell lung cancer.
Cell Physiol Biochem. 47:245–256. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li YL, Wang J, Zhang CY, Shen YQ, Wang HM,
Ding L, Gu YC, Lou JT, Zhao XT, Ma ZL and Jin YX: MiR-146a-5p
inhibits cell proliferation and cell cycle progression in NSCLC
cell lines by targeting CCND1 and CCND2. Oncotarget. 7:59287–59298.
2016.PubMed/NCBI
|
|
25
|
Wang Y, Xue J, Kuang H, Zhou X, Liao L and
Yin F: microRNA-1297 inhibits the growth and metastasis of
colorectal cancer by suppressing cyclin D2 expression. DNA Cell
Biol. 36:991–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
